Illinois healthcare titan Baxter (NYSE:BAX) isn’t getting much Wall Street love today after posting Q1 adjusted per-share earnings that blew away expectations.
2014
GE Healthcare’s Q1 sales, profits slide
GE Healthcare (NYSE:GE) saw its sales and profits decline by single digits during the 1st quarter due to "market volatility.”
GE Healthcare posted profits of $570 million on sales of $4.20 billion for the 3 months ended March 31, for a bottom-line decline of 4.2% and a top-line slide of 2.1% compared with the same period last year.
Urologix completes layoffs, announces preliminary results
Abbott’s earnings take a beating in Q1
St. Jude Medical beats The Street, loses points anyway
Minnesota medtech titan St. Jude Medical (NYSE:STJ) lost a few points on Wall Street today after posting 1st quarter earnings a penny above analysts’ consensus estimate.
Johnson & Johnson’s Q1 sales, earnings beat forecasts
Johnson & Johnson (NYSE:JNJ) topped expectations with its 1st-quarter results and raised its outlook for the rest of the year, sending share prices up this morning.
AngioDynamics swings to Q3 black, beats The Street
AngioDynamics (NSDQ:ANGO) put some black ink in the ledger during its fiscal 3rd quarter and handily topped Wall Street’s earnings forecast, but investors have remained unmoved, sending ANGO shares down 12% since its April 9 earnings release.
Intuitive Surgical drops on limp Q1 prelims
Intuitive Surgical (NSDQ:ISRG) lost some Wall Street favor last night after posting dim preliminary results for its 1st quarter of 2014.
Biomet slashes Q3 losses, sales rise nearly 7%
Biomet said today that it slashed its 3rd-quarter losses by nearly 80% and boosted sales by 6.6% as the privately-owned orthopedics giant prepares to go back on the stock market.
Warsaw, Ind.-based Biomet posted losses of -$65.9 million on sales of $822.5 million for the 3 months ended Feb. 28. Adjusted to exclude 1-time items, profits rose 13.1% compared with the same period last year, to $107.3 million.